Latest Breaking News On - Presentation details - Page 8 : comparemela.com

Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002 in Ulcerative Colitis at the 19th Congress of the European Crohn s and Colitis Organisation (ECCO)

22.02.2024 - Results of the Phase 2 trial of VTX002 (S1P1R modulator) in ulcerative colitis to be highlighted in oral presentation on February 22nd SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) - Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a . Seite 1

Raju mohanBrucee sandsBurrillb crohnColitis organisationIcahn school of medicineHenryd janowitz division of gastroenterologyEuropean crohnChief executivePresentation detailsIcahn schoolMount sinaiPlenary hallVentyx biosciences chartEntyx biosciences kursEntyx biosciences aktie

Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™

SOUTH SAN FRANCISCO, Calif., Feb. 01, 2024 Denali Therapeutics Inc. , a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier .

San diegoUnited statesSouth san franciscoLaura hansenJeaniner jarnesRobertj gorlinCase study demonstrates properties of rawHealth authorityEuropean medicines agencyExchange commissionDenali therapeutics incDrug administrationForum platform presentationsEnzyme transport vehiclePresentation detailsInterim analysis

Hillman Sets Fourth Quarter 2023 Earnings Release and Results Presentation Date

CINCINNATI, Feb. 01, 2024 Hillman Solutions Corp. , a leading provider of hardware products and merchandising solutions, plans to host a conference call to discuss its results for the thirteen.

United statesDoug cahillJon michael adinolfiMichael koehlerHillman solutions corpChief executive officer doug cahillChief financial officer rocky kraftChief operating officer jon michael adinolfiPresentation detailsOnly webcastListen only webcastHillman solutionsNorth americanInvestor relations

Hillman Sets Fourth Quarter 2023 Earnings Release And Results Presentation Date

Hillman Sets Fourth Quarter 2023 Earnings Release And Results Presentation Date
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesJon michael adinolfiMichael koehlerDoug cahillHillman solutions corpChief executive officer doug cahillChief financial officer rocky kraftChief operating officer jon michael adinolfiPresentation detailsOnly webcastListen only webcastHillman solutionsNorth americanInvestor relations

Molecular Partners Provides Updates at 42nd Annual J P Morgan Healthcare Conference - Molecular Partners (NASDAQ:MOLN)

Tetra-specific T-cell engager MP0533 for patients with r/r AML and AML/MDS on track to deliver expanded clinical phase 1/2a data in H1 2024Progress of Radio-DARPin Therapy (RDT) platform: Improved tumor to kidney uptake

San franciscoUnited statesPatrick amstutzLaura jeanbartAllergan abbvieHscs lscsSeth lewisAmerican society of hematologyHead of portfolio management communicationsAmerican societyAnnual meetingOrano medMolecular partnerPresentation detailsMolecular partnersPortfolio management